Flexion Therapeutics Inc 4 SEC Filings

Filed On	Filing
23 Nov 2021	Form 4: Newtyn Management, Llc, 10% owner Disposed of 5,900,000 shares (Tender Offer)
19 Nov 2021	Form 4: Stejbach Mark, Director Returned 12,631 shares to the issuer ($107K) · Disposed of 76,500 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Milinazzo Alan, Director Returned 27,450 shares to the issuer ($233K) · Disposed of 82,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Merrifield C Ann, Director Returned 19,000 shares to the issuer ($162K) · Disposed of 91,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Lukatch Heath, Director Returned 9,000 shares to the issuer ($76.5K) · Disposed of 48,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Kwo Elizabeth, Director Returned 4,500 shares to the issuer ($38.3K) · Disposed of 39,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Koppikar Utpal, Director Disposed of 32,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Colella Samuel D, Director Returned 1,496,564 shares to the issuer ($12.7M) · Disposed of 82,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Canute Scott A, Director Returned 9,000 shares to the issuer ($76.5K) · Disposed of 91,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Mahaffy Patrick J, Director Returned 39,824 shares to the issuer ($339K) · Disposed of 133,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Levine Mark S., General Counsel Returned 133,486 shares to the issuer ($1.13M) · Disposed of 211,833 Stock Option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Muzikant Adam, Chief Business Officer Returned 103,666 shares to the issuer ($881K) · Disposed of 112,667 Stock Option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Wentworth Kerry, Chief Regulatory Officer Returned 146,843 shares to the issuer ($1.25M) · Disposed of 185,833 Stock Option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Layman Melissa, Chief Commercial Officer Returned 103,956 shares to the issuer ($884K) · Disposed of 30,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 20,100 Performance Restricted Stock Unit Award (Disposition to Issuer)
19 Nov 2021	Form 4: Willwerth Christina, Chief Strategy Officer Returned 141,241 shares to the issuer ($1.2M) · Disposed of 209,663 Stock Option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Driscoll Frederick W, Chief Financial Officer Returned 30,680 shares to the issuer ($261K) · Disposed of 168,000 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Andrews William T., Chief Medical Officer Returned 34,250 shares to the issuer ($291K) · Disposed of 205,500 Stock option (right to buy) (Disposition to Issuer)
19 Nov 2021	Form 4: Clayman Michael D., Director Returned 1,122,550 shares to the issuer ($9.54M) · Disposed of 1,368,197 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 106,100 Performance Restricted Stock Unit Award (Disposition to Issuer)
04 Aug 2021	Form 4: Andrews William T., Chief Medical Officer Received 34,250 shares as a grant or award · Granted 205,500 Stock option (right to buy)
20 Jul 2021	Form 4: Willwerth Christina, Chief Strategy Officer Sold 3,945 shares ($25.4K)

Comments